{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T03:55:34Z","timestamp":1795146934323,"version":"4.10.3"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02944-w","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:48:10Z","timestamp":1759160890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Association of the triglyceride-glucose index and its combination with obesity indices with cardio-renal-metabolic multimorbidity: two decades of follow-up in the Tehran Lipid and Glucose Study"],"prefix":"10.1186","volume":"24","author":[{"given":"Soroush","family":"Soraneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Masrouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Tohidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Hadaegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"2944_CR1","doi-asserted-by":"crossref","unstructured":"Chowdhury SR, Das DC, Sunna TC, Beyene J, Hossain A. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. EClinicalMedicine. 2023;57:101860.","DOI":"10.1016\/j.eclinm.2023.101860"},{"issue":"1","key":"2944_CR2","doi-asserted-by":"publisher","first-page":"e049133","DOI":"10.1136\/bmjopen-2021-049133","volume":"12","author":"OA Asogwa","year":"2022","unstructured":"Asogwa OA, Boateng D, Marz\u00e0-Florensa A, Peters S, Levitt N, van Olmen J, et al. Multimorbidity of non-communicable diseases in low-income and middle-income countries: a systematic review and meta-analysis. BMJ Open. 2022;12(1):e049133.","journal-title":"BMJ Open"},{"key":"2944_CR3","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1136\/bmj.p2327","volume":"383","author":"K Khunti","year":"2023","unstructured":"Khunti K, Sathanapally H, Mountain P. Multiple long term conditions, multimorbidity, and co-morbidities: we should reconsider the terminology we use. BMJ. 2023;383:2327.","journal-title":"BMJ"},{"issue":"12","key":"2944_CR4","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/dom.14829","volume":"24","author":"T Kadowaki","year":"2022","unstructured":"Kadowaki T, Maegawa H, Watada H, Yabe D, Node K, Murohara T, et al. Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan. Diabetes Obes Metabolism. 2022;24(12):2283\u201396.","journal-title":"Diabetes Obes Metabolism"},{"issue":"20","key":"2944_CR5","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"11","key":"2944_CR6","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jamacardio.2023.3241","volume":"8","author":"JW Ostrominski","year":"2023","unstructured":"Ostrominski JW, Arnold SV, Butler J, Fonarow GC, Hirsch JS, Palli SR, et al. Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999\u20132020. JAMA Cardiol. 2023;8(11):1050\u201360.","journal-title":"JAMA Cardiol"},{"issue":"20","key":"2944_CR7","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of Cardiovascular-Kidney-Metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"7","key":"2944_CR8","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2944_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12933-024-02392-y","volume":"23","author":"SS Nayak","year":"2024","unstructured":"Nayak SS, Kuriyakose D, Polisetty LD, Patil AA, Ameen D, Bonu R, et al. Diagnostic and prognostic value of triglyceride glucose index: a comprehensive evaluation of meta-analysis. Cardiovasc Diabetol. 2024;23(1):310.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2944_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13098-023-01205-8","volume":"15","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhao L, Lu Y, Meng X, Zhou X. Relationship of triglyceride-glucose index with cardiometabolic multi-morbidity in China: evidence from a National survey. Diabetol Metab Syndr. 2023;15(1):226.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2944_CR11","doi-asserted-by":"publisher","first-page":"e3764","DOI":"10.1002\/dmrr.3764","volume":"40","author":"D Xiao","year":"2024","unstructured":"Xiao D, Sun H, Chen L, Li X, Huo H, Zhou G, et al. Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle-aged and older populations: insights from the China health and retirement longitudinal study. Diab\/Metab Res Rev. 2024;40(1):e3764.","journal-title":"Diab\/Metab Res Rev"},{"key":"2944_CR12","doi-asserted-by":"crossref","unstructured":"Liu J, Liu Z, Zhou Y, Liu Y, Song W, Wang N et al. The joint effect of triglyceride-glucose related indices and depression on cardio-renal-metabolic Multimorbidity among middle-aged and older Chinese adults. J Affect Disord. 2025;382:549\u201357.","DOI":"10.1016\/j.jad.2025.04.072"},{"issue":"1","key":"2944_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12933-025-02693-w","volume":"24","author":"H Tang","year":"2025","unstructured":"Tang H, Huang J, Zhang X, Chen X, Yang Q, Luo N, et al. Association between triglyceride glucose-body mass index and the trajectory of cardio-renal-metabolic multimorbidity: insights from multi-state modelling. Cardiovasc Diabetol. 2025;24(1):133.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2944_CR14","doi-asserted-by":"publisher","first-page":"15499","DOI":"10.1038\/s41598-023-42341-5","volume":"13","author":"J Khanali","year":"2023","unstructured":"Khanali J, Ghasemi E, Rashidi M-M, Ahmadi N, Ghamari S-H, Azangou-Khyavy M, et al. Prevalence of plasma lipid abnormalities and associated risk factors among Iranian adults based on the findings from steps survey 2021. Sci Rep. 2023;13(1):15499.","journal-title":"Sci Rep"},{"issue":"2","key":"2944_CR15","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s40200-023-01310-5","volume":"22","author":"N Efazati","year":"2023","unstructured":"Efazati N, Hoseini Tavassol Z, khalagi K, Mahmudimanesh M, Tabatabaei-Malazy O, Khalili D, et al. General and abdominal obesity trends in the Iranian adult population from 2004 to 2021. J Diabetes Metabolic Disorders. 2023;22(2):1745\u201361.","journal-title":"J Diabetes Metabolic Disorders"},{"issue":"1","key":"2944_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2944_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-025-02662-3","volume":"24","author":"J Hong","year":"2025","unstructured":"Hong J, Zhang R, Tang H, Wu S, Chen Y, Tan X. Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):98.","journal-title":"Cardiovasc Diabetol"},{"key":"2944_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/nu11112654","volume":"11","author":"R Ram\u00edrez-V\u00e9lez","year":"2019","unstructured":"Ram\u00edrez-V\u00e9lez R, P\u00e9rez-Sousa M, Gonz\u00e1lez-Ru\u00edz K, Cano-Gutierrez CA, Schmidt-RioValle J, Correa-Rodr\u00edguez M, et al. Obesity- and lipid-related parameters in the identification of older adults with a high risk of prediabetes according to the American diabetes association: an analysis of the 2015 health, well-being, and aging study. Nutrients. 2019;11:11.","journal-title":"Nutrients"},{"issue":"1","key":"2944_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","volume":"24","author":"Z Tian","year":"2025","unstructured":"Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank. Cardiovasc Diabetol. 2025;24(1):257.","journal-title":"Cardiovasc Diabetol"},{"key":"2944_CR20","doi-asserted-by":"crossref","unstructured":"Lan Y, Qi G, Li B, Sooranna SR, Chen D, Rao W et al. Association of the triglyceride-glucose index and obesity indicators with multiple chronic diseases: a longitudinal cohort study based on CHARLS. J Multidiscip Healthc. 2025;18:171\u201382.","DOI":"10.2147\/JMDH.S496304"},{"key":"2944_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12933-025-02873-8","volume":"24","author":"J Qiu","year":"2025","unstructured":"Qiu J, Li Je, Xu S, Yang J, Zeng H, Zhang Y, et al. Triglyceride glucose-weight-adjusted waist index as a cardiovascular mortality predictor: incremental value beyond the establishment of TyG-related indices. Cardiovasc Diabetol. 2025;24:306.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"2944_CR22","doi-asserted-by":"publisher","first-page":"734","DOI":"10.18632\/aging.100505","volume":"4","author":"F Pintus","year":"2012","unstructured":"Pintus F, Floris G, Rufini A. Nutrient availability links mitochondria, apoptosis, and obesity. Aging. 2012;4(11):734.","journal-title":"Aging"},{"key":"2944_CR23","doi-asserted-by":"publisher","first-page":"890","DOI":"10.2741\/4758","volume":"24","author":"RT Atawia","year":"2019","unstructured":"Atawia RT, Bunch KL, Toque HA, Caldwell RB, Caldwell RW. Mechanisms of obesity-induced metabolic and vascular dysfunctions. Front Biosci (Landmark edition). 2019;24:890.","journal-title":"Front Biosci (Landmark edition)"},{"key":"2944_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-6215-10-5","volume":"10","author":"F Azizi","year":"2009","unstructured":"Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.","journal-title":"Trials"},{"issue":"6","key":"2944_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.clinbiochem.2014.02.007","volume":"47","author":"M Tohidi","year":"2014","unstructured":"Tohidi M, Ghasemi A, Hadaegh F, Derakhshan A, Chary A, Azizi F. Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance\/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study. Clin Biochem. 2014;47(6):432\u20138.","journal-title":"Clin Biochem"},{"issue":"7","key":"2944_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"19","key":"2944_CR27","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"2","key":"2944_CR28","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12020-018-1685-2","volume":"62","author":"A Ghasemi","year":"2018","unstructured":"Ghasemi A, Asgari S, Hadaegh F, Kheirandish M, Azimzadeh I, Azizi F, et al. New modified Friedewald formulae for estimating low-density lipoprotein cholesterol according to triglyceride levels: extraction and validation. Endocrine. 2018;62(2):404\u201311.","journal-title":"Endocrine"},{"issue":"4","key":"2944_CR29","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41440-023-01502-9","volume":"47","author":"H Miao","year":"2024","unstructured":"Miao H, Zhou Z, Yang S, Zhang Y. The association of triglyceride-glucose index and related parameters with hypertension and cardiovascular risk: a cross-sectional study. Hypertens Res. 2024;47(4):877\u201386.","journal-title":"Hypertens Res"},{"issue":"24","key":"2944_CR30","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1001\/jama.2014.6634","volume":"311","author":"J Coresh","year":"2014","unstructured":"Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518\u201331.","journal-title":"JAMA"},{"issue":"12","key":"2944_CR31","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/ajh\/hpz105","volume":"32","author":"N Rathi","year":"2019","unstructured":"Rathi N, Whelton PK, Chertow GM, Cushman WC, Cheung AK, Wei G, et al. Influence of prediabetes on the effects of intensive systolic blood pressure control on kidney events. Am J Hypertens. 2019;32(12):1170\u20137.","journal-title":"Am J Hypertens"},{"issue":"6","key":"2944_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.7326\/M16-2966","volume":"167","author":"S Beddhu","year":"2017","unstructured":"Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, et al. Effects of intensive systolic blood pressure control on kidney and cardiovascular outcomes in persons without kidney disease: a secondary analysis of a randomized trial. Ann Intern Med. 2017;167(6):375\u201383.","journal-title":"Ann Intern Med"},{"issue":"7","key":"2944_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S2213-8587(18)30099-8","volume":"6","author":"S Beddhu","year":"2018","unstructured":"Beddhu S, Greene T, Boucher R, Cushman WC, Wei G, Stoddard G, et al. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials. Lancet Diabetes Endocrinol. 2018;6(7):555\u201363.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2944_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/j.ajkd.2014.11.009","volume":"66","author":"CM Rebholz","year":"2015","unstructured":"Rebholz CM, Grams ME, Matsushita K, Selvin E, Coresh J. Change in novel filtration markers and risk of ESRD. Am J Kidney Dis. 2015;66(1):47\u201354.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2944_CR35","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2215\/CJN.09770915","volume":"11","author":"LJ Maple-Brown","year":"2016","unstructured":"Maple-Brown LJ, Hughes JT, Ritte R, Barzi F, Hoy WE, Lawton PD, et al. Progression of kidney disease in Indigenous australians: the eGFR follow-up study. Clin J Am Soc Nephrol. 2016;11(6):993\u20131004.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"2944_CR36","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/jdi.14308","volume":"15","author":"S Masrouri","year":"2024","unstructured":"Masrouri S, Tamehri Zadeh SS, Tohidi M, Azizi F, Hadaegh F. Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: insights from the TLGS. J Diabetes Investig. 2024;15(12):1743\u201352.","journal-title":"J Diabetes Investig"},{"issue":"25","key":"2944_CR37","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP)","year":"2002","unstructured":"Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143\u2013421.","journal-title":"Circulation"},{"issue":"3","key":"2944_CR38","first-page":"243","volume":"13","author":"F Azizi","year":"2010","unstructured":"Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13(3):243\u20134.","journal-title":"Arch Iran Med"},{"issue":"4 Suppl","key":"2944_CR39","first-page":"e84748","volume":"16","author":"D Khalili","year":"2018","unstructured":"Khalili D, Azizi F, Asgari S, Zadeh-Vakili A, Momenan AA, Ghanbarian A, et al. Outcomes of a longitudinal Population-based cohort study and pragmatic community trial: findings from 20 years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018;16(4 Suppl):e84748.","journal-title":"Int J Endocrinol Metab"},{"issue":"8","key":"2944_CR40","doi-asserted-by":"publisher","first-page":"e587","DOI":"10.1016\/S2468-2667(21)00107-9","volume":"6","author":"IS Ho","year":"2021","unstructured":"Ho IS, Azcoaga-Lorenzo A, Akbari A, Black C, Davies J, Hodgins P, et al. Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies. Lancet Public Health. 2021;6(8):e587\u201397.","journal-title":"Lancet Public Health"},{"key":"2944_CR41","doi-asserted-by":"publisher","first-page":"163406","DOI":"10.1016\/j.scitotenv.2023.163406","volume":"881","author":"G Wu","year":"2023","unstructured":"Wu G, Cai M, Wang C, Zou H, Wang X, Hua J, et al. Ambient air pollution and incidence, progression to multimorbidity and death of hypertension, diabetes, and chronic kidney disease: a national prospective cohort. Sci Total Environ. 2023;881:163406.","journal-title":"Sci Total Environ"},{"issue":"1","key":"2944_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12933-024-02347-3","volume":"23","author":"N Zhang","year":"2024","unstructured":"Zhang N, Liu X, Wang L, Zhang Y, Xiang Y, Cai J, et al. Lifestyle factors and their relative contributions to longitudinal progression of cardio-renal-metabolic multimorbidity: a prospective cohort study. Cardiovasc Diabetol. 2024;23(1):265.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2944_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-020-01121-5","volume":"19","author":"N Barzegar","year":"2020","unstructured":"Barzegar N, Tohidi M, Hasheminia M, Azizi F, Hadaegh F. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study. Cardiovasc Diabetol. 2020;19(1):155.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2944_CR44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12933-024-02457-y","volume":"23","author":"J-H Lee","year":"2024","unstructured":"Lee J-H, Jeon S, Lee HS, Lee J-W. Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis. Cardiovasc Diabetol. 2024;23(1):364.","journal-title":"Cardiovasc Diabetol"},{"issue":"25 Pt B","key":"2944_CR45","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","volume":"63","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr., Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Sr., Gibbons R, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2935\u201359.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2944_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12933-023-02054-5","volume":"22","author":"J Chen","year":"2023","unstructured":"Chen J, Wu K, Lin Y, Huang M, Xie S. Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Cardiovasc Diabetol. 2023;22(1):320.","journal-title":"Cardiovasc Diabetol"},{"issue":"446","key":"2944_CR47","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"2944_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bmjph-2024-000963","volume":"2","author":"MR Baneshi","year":"2024","unstructured":"Baneshi MR, Mishra G, Dobson A. Comparison of seven models for the progression patterns of multiple chronic conditions in longitudinal studies. BMJ Public Health. 2024;2:2.","journal-title":"BMJ Public Health"},{"key":"2944_CR49","doi-asserted-by":"crossref","unstructured":"Hua R, Yang A, Gao L, Chow E, Ji W, Cheung YT. Social determinants of health and progression to cardio\u2013renal\u2013metabolic multimorbidity and mortality in people with prediabetes: a prospective cohort study. Diabetes, Obesity and Metabolism; 2025.","DOI":"10.1111\/dom.70067"},{"issue":"4","key":"2944_CR50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377\u201399.","journal-title":"Stat Med"},{"key":"2944_CR51","unstructured":"Rubin DB. Multiple imputation. In: Flexible imputation of missing data, second edition. Chapman and Hall\/CRC; 2018. pp. 29\u201362."},{"key":"2944_CR52","doi-asserted-by":"publisher","first-page":"d40","DOI":"10.1136\/bmj.d40","volume":"342","author":"IR White","year":"2011","unstructured":"White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ. 2011;342:d40.","journal-title":"BMJ"},{"key":"2944_CR53","doi-asserted-by":"crossref","unstructured":"Little RJ, Rubin DB. Statistical analysis with missing data. Wiley, Hoboken; 2019.","DOI":"10.1002\/9781119482260"},{"issue":"11","key":"2944_CR54","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157\u201372.","journal-title":"Circulation"},{"issue":"1","key":"2944_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1573403X14666180711124825","volume":"15","author":"NG Vallianou","year":"2019","unstructured":"Vallianou NG, Mitesh S, Gkogkou A, Geladari E. Chronic kidney disease and cardiovascular disease: Is there any relationship? Curr Cardiol Rev. 2019;15(1):55\u201363.","journal-title":"Curr Cardiol Rev"},{"issue":"1","key":"2944_CR56","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12933-024-02269-0","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C, Liang D, Xiao K, Xie L. Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024;23(1):171.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2944_CR57","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-025-02642-7","volume":"24","author":"P Zhang","year":"2025","unstructured":"Zhang P, Mo D, Zeng W, Dai H. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a cohort study. Cardiovasc Diabetol. 2025;24(1):92.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2944_CR58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10238-024-01472-3","volume":"24","author":"C Fan","year":"2024","unstructured":"Fan C, Guo M, Chang S, Wang Z, An T. Elevated TyG-BMI index predicts incidence of chronic kidney disease. Clin Exp Med. 2024;24(1):203.","journal-title":"Clin Exp Med"},{"issue":"1","key":"2944_CR59","doi-asserted-by":"publisher","first-page":"20593","DOI":"10.1038\/s41598-024-71579-w","volume":"14","author":"T Chen","year":"2024","unstructured":"Chen T, Wan H, Luo Y, Chen L. Association of triglyceride-glucose-body mass index with all-cause and cardiovascular mortality among individuals with chronic kidney disease. Sci Rep. 2024;14(1):20593.","journal-title":"Sci Rep"},{"issue":"1","key":"2944_CR60","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):292.","journal-title":"Cardiovasc Diabetol"},{"issue":"16","key":"2944_CR61","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the American Heart Association. Circulation. 2019;139(16):e840\u201378.","journal-title":"Circulation"},{"issue":"3","key":"2944_CR62","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275\u201386.","journal-title":"Obes Rev"},{"issue":"3","key":"2944_CR63","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity. Nat Rev Endocrinol. 2020;16(3):177\u201389.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2944_CR64","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12933-022-01729-9","volume":"21","author":"X Tian","year":"2022","unstructured":"Tian X, Chen S, Wang P, Xu Q, Zhang Y, Luo Y, et al. Insulin resistance mediates obesity-related risk of cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):289.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2944_CR65","doi-asserted-by":"publisher","first-page":"e0212963","DOI":"10.1371\/journal.pone.0212963","volume":"14","author":"J Lim","year":"2019","unstructured":"Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007\u20132010 Korean National Health and Nutrition Examination Survey. PLoS ONE. 2019;14(3):e0212963.","journal-title":"PLoS ONE"},{"issue":"1","key":"2944_CR66","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/j.jacl.2023.11.006","volume":"18","author":"H-M Park","year":"2024","unstructured":"Park H-M, Han T, Heo S-J, Kwon Y-J. Effectiveness of the triglyceride-glucose index and triglyceride-glucose-related indices in predicting cardiovascular disease in middle-aged and older adults: a prospective cohort study. J Clin Lipidol. 2024;18(1):e70\u20139.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"2944_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12933-025-02591-1","volume":"24","author":"C Li","year":"2025","unstructured":"Li C, Zhang Z, Luo X, Xiao Y, Tu T, Liu C, et al. The triglyceride\u2013glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis. Cardiovasc Diabetol. 2025;24(1):47.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2944_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12933-024-02278-z","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Qi Y, Song J, Shang X, Han T, Han N, et al. Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults. Cardiovasc Diabetol. 2024;23(1):185.","journal-title":"Cardiovasc Diabetol"},{"key":"2944_CR69","doi-asserted-by":"crossref","unstructured":"Ke P, Wu X, Xu M, Feng J, Xu H, Gan Y et al. Comparison of obesity indices and triglyceride glucose-related parameters to predict type 2 diabetes mellitus among normal-weight elderly in China. Eat Weight Disord Stud Anorex Bulim Obes. 2022;27(3):1181\u201391.","DOI":"10.1007\/s40519-021-01238-w"},{"issue":"1","key":"2944_CR70","doi-asserted-by":"publisher","first-page":"20942","DOI":"10.1038\/s41598-024-71914-1","volume":"14","author":"X Feng","year":"2024","unstructured":"Feng X, Zhu J, Hua Z, Yao S, Tong H. Comparison of obesity indicators for predicting cardiovascular risk factors and multimorbidity among the Chinese population based on ROC analysis. Sci Rep. 2024;14(1):20942.","journal-title":"Sci Rep"},{"issue":"3","key":"2944_CR71","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/ajcn\/84.3.483","volume":"84","author":"C Meisinger","year":"2006","unstructured":"Meisinger C, D\u00f6ring A, Thorand B, Heier M, L\u00f6wel H. Body fat distribution and risk of type 2 diabetes in the general population: Are there differences between men and women? The MONICA\/KORA Augsburg cohort study. Am J Clin Nutr. 2006;84(3):483\u20139.","journal-title":"Am J Clin Nutr"},{"key":"2944_CR72","doi-asserted-by":"publisher","first-page":"1426749","DOI":"10.3389\/fnut.2024.1426749","volume":"11","author":"W Xie","year":"2024","unstructured":"Xie W, Hong Y, Chen X, Wang S, Zhang F, Chi X. Waist-to-hip ratio and nonalcoholic fatty liver disease: a clinical observational and Mendelian randomization analysis. Front Nutr. 2024;11:1426749.","journal-title":"Front Nutr"},{"issue":"6","key":"2944_CR73","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.2337\/dc09-2110","volume":"33","author":"KJ Ausk","year":"2010","unstructured":"Ausk KJ, Boyko EJ, Ioannou GN. Insulin resistance predicts mortality in nondiabetic individuals in the US. Diabetes Care. 2010;33(6):1179\u201385.","journal-title":"Diabetes Care"},{"issue":"1","key":"2944_CR74","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13098-024-01307-x","volume":"16","author":"Q Shangguan","year":"2024","unstructured":"Shangguan Q, Liu Q, Yang R, Zhang S, Sheng G, Kuang M, et al. Predictive value of insulin resistance surrogates for the development of diabetes in individuals with baseline normoglycemia: findings from two independent cohort studies in China and Japan. Diabetol Metab Syndr. 2024;16(1):68.","journal-title":"Diabetol Metab Syndr"},{"key":"2944_CR75","doi-asserted-by":"publisher","first-page":"784616","DOI":"10.3389\/fendo.2021.784616","volume":"12","author":"S Zou","year":"2021","unstructured":"Zou S, Yang C, Shen R, Wei X, Gong J, Pan Y, et al. Association between the triglyceride\u2013glucose index and the incidence of diabetes in people with different phenotypes of obesity: a retrospective study. Front Endocrinol. 2021;12:784616.","journal-title":"Front Endocrinol"},{"key":"2944_CR76","doi-asserted-by":"crossref","unstructured":"Kim B, Kim GM, Huh U, Lee J, Kim E. Association of HOMA-IR versus TyG index with diabetes in individuals without underweight or obesity. Healthcare (Basel). 2024;12(23):2458.","DOI":"10.3390\/healthcare12232458"},{"issue":"9","key":"2944_CR77","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1161\/ATVBAHA.123.319200","volume":"43","author":"JH Lee","year":"2023","unstructured":"Lee JH, Jeon S, Joung B, Lee HS, Kwon YJ. Associations of homeostatic model assessment for insulin resistance trajectories with cardiovascular disease incidence and mortality. Arterioscler Thromb Vasc Biol. 2023;43(9):1719\u201328.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2944_CR78","doi-asserted-by":"crossref","unstructured":"Ndumele CE, Matsushita K, Lazo M, Bello N, Blumenthal RS, Gerstenblith G et al. Obesity and subtypes of incident cardiovascular disease. J Am Heart Assoc. 2016;5(8):e003921.","DOI":"10.1161\/JAHA.116.003921"},{"issue":"6","key":"2944_CR79","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/obr.12157","volume":"15","author":"JA Bell","year":"2014","unstructured":"Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev. 2014;15(6):504\u201315.","journal-title":"Obes Rev"},{"issue":"1","key":"2944_CR80","first-page":"4678526","volume":"2020","author":"A S\u00e1nchez-Garc\u00eda","year":"2020","unstructured":"S\u00e1nchez-Garc\u00eda A, Rodr\u00edguez-Guti\u00e9rrez R, Mancillas-Adame L, Gonz\u00e1lez-Nava V, D\u00edaz Gonz\u00e1lez-Colmenero A, Solis RC, et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol. 2020;2020(1):4678526.","journal-title":"Int J Endocrinol"},{"issue":"12","key":"2944_CR81","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.numecd.2022.07.024","volume":"32","author":"SA Nabipoorashrafi","year":"2022","unstructured":"Nabipoorashrafi SA, Seyedi SA, Rabizadeh S, Ebrahimi M, Ranjbar SA, Reyhan SK, et al. The accuracy of triglyceride-glucose (TyG) index for the screening of metabolic syndrome in adults: a systematic review and meta-analysis. Nutr Metabolism Cardiovasc Dis. 2022;32(12):2677\u201388.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"issue":"4 Suppl","key":"2944_CR82","first-page":"e84777","volume":"16","author":"F Azizi","year":"2018","unstructured":"Azizi F, Zadeh-Vakili A, Takyar M. Review of rationale, design, and initial findings: Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018;16(4 Suppl):e84777.","journal-title":"Int J Endocrinol Metab"},{"issue":"1","key":"2944_CR83","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1186\/s12872-024-04407-8","volume":"24","author":"L Liu","year":"2024","unstructured":"Liu L, Sun H, Yi L, Wang G, Zou Y. Association between triglyceride-glucose index and cardiovascular disease in US adults with chronic kidney disease: a population-based study. BMC Cardiovasc Disord. 2024;24(1):723.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2944_CR84","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13098-023-01161-3","volume":"15","author":"X Wang","year":"2023","unstructured":"Wang X, Liu Q, Wang T, Tian W, Chen X, Zhang J, et al. Triglyceride-glucose index and the risk of stroke in American adults: findings from the atherosclerosis risk in communities study. Diabetol Metab Syndr. 2023;15(1):187.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2944_CR85","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12872-025-04853-y","volume":"25","author":"J Huang","year":"2025","unstructured":"Huang J, Chen J, Pan G, Zheng L, Weng J, Weng C, et al. Association between triglyceride glucose-waist to height ratio (TyG-WHtR) and hypertension in adults aged 18\u201360: a cross-sectional study. BMC Cardiovasc Disord. 2025;25(1):403.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2944_CR86","doi-asserted-by":"publisher","first-page":"31352","DOI":"10.1038\/s41598-024-82881-y","volume":"14","author":"L Wu","year":"2024","unstructured":"Wu L, Huang Z. Elevated triglyceride glucose index is associated with advanced cardiovascular kidney metabolic syndrome. Sci Rep. 2024;14(1):31352.","journal-title":"Sci Rep"},{"issue":"1","key":"2944_CR87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-024-02571-x","volume":"24","author":"Y Huang","year":"2025","unstructured":"Huang Y, Zhou Y, Xu Y, Wang X, Zhou Z, Wu K, et al. Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts. Cardiovasc Diabetol. 2025;24(1):11.","journal-title":"Cardiovasc Diabetol"},{"key":"2944_CR88","doi-asserted-by":"publisher","first-page":"1452896","DOI":"10.3389\/fendo.2024.1452896","volume":"15","author":"M Yang","year":"2024","unstructured":"Yang M, Shangguan Q, Xie G, Sheng G, Yang J. Oxidative stress mediates the association between triglyceride-glucose index and risk of cardiovascular and all-cause mortality in metabolic syndrome: evidence from a prospective cohort study. Front Endocrinol (Lausanne). 2024;15:1452896.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2944_CR89","doi-asserted-by":"publisher","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","volume":"119","author":"E Muzurovi\u0107","year":"2021","unstructured":"Muzurovi\u0107 E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism. 2021;119:154770.","journal-title":"Metabolism"},{"key":"2944_CR90","doi-asserted-by":"publisher","first-page":"111705","DOI":"10.1016\/j.diabres.2024.111705","volume":"212","author":"S Liu","year":"2024","unstructured":"Liu S, Sun H, Liu J, Wang G. Accessing the relationship between six surrogate insulin resistance indexes and the incidence of rapid kidney function decline and the progression to chronic kidney disease among middle-aged and older adults in china: results from the China health and retirement longitudinal study. Diabetes Res Clin Pract. 2024;212:111705.","journal-title":"Diabetes Res Clin Pract"},{"key":"2944_CR91","doi-asserted-by":"crossref","unstructured":"Oh D, Park SH, Lee S, Yang E, Choi HY, Park HC et al. High triglyceride-glucose index with renal hyperfiltration and albuminuria in young adults: the Korea National Health and Nutrition Examination Survey (KNHANES V, VI, and VIII). J Clin Med. 2022;11(21):6419.","DOI":"10.3390\/jcm11216419"},{"issue":"3","key":"2944_CR92","doi-asserted-by":"publisher","first-page":"e212612","DOI":"10.1001\/jamanetworkopen.2021.2612","volume":"4","author":"J Fritz","year":"2021","unstructured":"Fritz J, Brozek W, Concin H, Nagel G, Kerschbaum J, Lhotta K, et al. The triglyceride-glucose index and obesity-related risk of end-stage kidney disease in Austrian adults. JAMA Netw Open. 2021;4(3):e212612.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2944_CR93","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2337\/dc08-1195","volume":"32","author":"K Faerch","year":"2009","unstructured":"Faerch K, Vaag A, Holst JJ, Hansen T, J\u00f8rgensen T, Borch-Johnsen K. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care. 2009;32(3):439\u201344.","journal-title":"Diabetes Care"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02944-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02944-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02944-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:03:53Z","timestamp":1759161833000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02944-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2944"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02944-w","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval of this study has been certified by the central institutional review board of the Research Institute of Endocrine Science, Shahid Beheshti University of Medical Science, Tehran, Iran. The outlined principles in the Declaration of Helsinki have been respected in this study. All participants have signed written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"369"}}